中访网数据 江中药业股份有限公司于2025年10月21日披露,其控股股东华润江中制药集团有限责任公司已顺利完成股份增持计划。根据公告,自2024年10月22日至2025年10月21日期间,华润江中通过上海证券交易所集中竞价交易系统累计增持公司股份2,844,550股,占公司总股本的0.45%,累计增持金额达61,292,218.30元(不含交易费用)。此次增持完成后,华润江中及其一致行动人...
Source Link中访网数据 江中药业股份有限公司于2025年10月21日披露,其控股股东华润江中制药集团有限责任公司已顺利完成股份增持计划。根据公告,自2024年10月22日至2025年10月21日期间,华润江中通过上海证券交易所集中竞价交易系统累计增持公司股份2,844,550股,占公司总股本的0.45%,累计增持金额达61,292,218.30元(不含交易费用)。此次增持完成后,华润江中及其一致行动人...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.